Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 87 of 5217 for:    neuromuscular disease

Impact of the Pre-phonatory Inspiratory Volume on the Speech Quality of Neuromuscular Patients Dependent on Non-invasive Ventilation (PREPHONO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03381937
Recruitment Status : Recruiting
First Posted : December 22, 2017
Last Update Posted : August 30, 2019
Sponsor:
Information provided by (Responsible Party):
Centre d'Investigation Clinique et Technologique 805

Brief Summary:
We want to demonstrate that modifications of the ventilation parameters are liable to improve the different characteristics of phonation (duration, intensity, prosody..) in neuromuscular patients who are dependent on non invasive ventilation.

Condition or disease Intervention/treatment Phase
Neuromuscular Diseases Non Invasive Ventilation Other: speech trial Not Applicable

Detailed Description:

Speech and communication quality depend on respiration efficiency. The respiratory involvement observed in neuromuscular disorders can impair speech quality in patients, while the underlying disease may also contribute to alter phonation.

Nowadays, the first line treatment of neuromuscular chronic neuromuscular respiratory failure is noninvasive ventilation (NIV). With disease progression, it is used with increasingly duration during daytime. In that situation, mouthpiece ventilation is preferred as it allows efficient ventilation while being more comfortable for patients who can chose when they want to be ventilated. However, in that situation, patients do not receive ventilatory support while they are speaking which puts them in a less favorable situation for speech. We think that pre-phonation inspiratory volume is an essential part of speech quality. Without mechanical ventilation, this volume is reduced as a consequence of respiratory failure but it is liable to increase significantly if the patient used the volume delivered by the ventilator .

We believe that phonation is improved by NIV by applying specific ventilation parameters in patients dependant on mechanical ventilation. The modification could be used by neuromuscular patients to improve speech quality; the patients would then be able to use their usual ventilatory support to improve phonation and modulation of their speech.

In this crossover open labelled, randomised study, done in a single center (home ventilation unit of the referral center of Hospital Raymond Poincaré HUPIFO (University Hospital of Western Paris and Ile de France) (Garches, France)), phonation characteristics will be studied in 3 situations (during spontaneous breathing without ventilatory support, with the usual NIV parameters, with speech-specific NIV parameters) during which speech trials will be performed.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: monocentric, open, randomize, crossover study
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Impact of the Pre-phonatory Inspiratory Volume on the Speech Quality of Neuromuscular Patients Dependent on Non-invasive Ventilation
Actual Study Start Date : February 6, 2018
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020

Arm Intervention/treatment
No Intervention: Spontaneous breathing
Spontaneous breathing without mechanical ventilation
Experimental: Conventional mechanical ventilation
Conventional mechanical ventilation, with patient ventilator usual parameters
Other: speech trial
speech trial during different ventilation conditions

Experimental: Speech specific mechanical ventilation
Mechanical ventilation with specific parameters to improve speech
Other: speech trial
speech trial during different ventilation conditions




Primary Outcome Measures :
  1. Phonation duration [ Time Frame: 1 hour ]
    evaluation by the measurement of the longest duration of a sustained A sound. The subject is asked to sustain a vowel as long as possible during a respiratory cycle while being recorded. Phonation duration is measured (in seconds) on the recording


Secondary Outcome Measures :
  1. Speech Intelligibility [ Time Frame: 1 hour ]
    assessment of intelligibility during reading of preselected words by listeners blinded to ventilation condition with a validated scale

  2. Quality of prosodia [ Time Frame: 1 hour ]
    evaluation of prosodia by listeners blinded to ventilation condition with a score based on the number of correct identification

  3. Phonation flow [ Time Frame: 1 hour ]
    Measurement of the number of syllables/min during the reading of a predetermined text

  4. Reading duration [ Time Frame: 1 hour ]
    Measurement of the duration for the reading of a predetermined text

  5. Phonation quality [ Time Frame: 1 hour ]
    evaluation of the phonation quality by the patient with a horizontal visual analogical scale ranked from 0 to 10 (0= very poor quality and 10= very good quality). The scale is 10 cm long ; the patient indicate his perceived sensation on the scale and the according measure (between 0 and 10) is recorded

  6. Breathing quality [ Time Frame: 1 hour ]
    evaluation of the breating quality during speech in each condition by the patient with a horizontal visual analogical scale ranked from 0 to 10 (0= very uncomfortable and 10= very comfortable). The scale is 10 cm long ; the patient indicate his perceived sensation and the according measure (between 0 and 10) is recorded



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adult patients (age > or equal to 18)
  • chronic restrictive respiratory failure due to neuromuscular disease
  • spontaneous breathing autonomy of at least one hour during the days
  • stable clinical state
  • patient with middle school education level (able to read)
  • patients using life support ventilator ((Astral 150 (ResMed®), Elysée (ResMed®), Trilogy (Philips Respironics®), VentilogicLS (Weinman®), Vivo 40 (Breas®), PB560 ou Légendair (Covidien®), Monal T50 (Air liquide system®))

Exclusion Criteria:

  • refusal to participate
  • unability to cooperate
  • illiterate patients
  • tracheostomised patients
  • spontaneous breathing autonomy < 1h
  • cardiovascular instability
  • not registered with the social security system

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03381937


Contacts
Layout table for location contacts
Contact: Hélène Prigent, MD PhD 0033147107911 helene.prigent@aphp.fr

Locations
Layout table for location information
France
Raymond Poincaré hospital Recruiting
Garches, France, 92380
Contact: Hélène Prigent, MD, PhD    0033147107911    helene.prigent@aphp.fr   
Principal Investigator: Hélène Prigent, MD PhD         
Sponsors and Collaborators
Centre d'Investigation Clinique et Technologique 805

Layout table for additonal information
Responsible Party: Centre d'Investigation Clinique et Technologique 805
ClinicalTrials.gov Identifier: NCT03381937     History of Changes
Other Study ID Numbers: 2017-A00705-48
First Posted: December 22, 2017    Key Record Dates
Last Update Posted: August 30, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Centre d'Investigation Clinique et Technologique 805:
mechanical ventilation
noninvasive ventilation
neuromuscular disorder
phonation
mouthpiece ventilation
Additional relevant MeSH terms:
Layout table for MeSH terms
Neuromuscular Diseases
Nervous System Diseases